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The Possible Role of PSD-95 in the Rearrangement of Kv1.3 Channels to
the Immunological Synapse
Orsolya Szila´gyi, Anita Boratko´, Gyo¨rgy Panyi, Pe´ter Hajdu.
University of Debrecen, Medical and Health Science Center, Debrecen,
Hungary.
T lymphocytes play a crucial role in the adaptive immune response. They are
activated through an interaction with antigen presenting cells during the estab-
lishment of the immunological synapse (IS). It is well documented that several
proteins accumulate in the IS. We have previously shown that one of these mol-
ecules is the voltage-gated potassium channel, Kv1.3. However, the mechanism
of this translocation and its consequences still remain unknown. It has been an-
ticipated that Kv1.3 channels interact with proteins from the MAGUK family:
PSD-95 and SAP97. These two proteins could regulate the cell surface expres-
sion and phosphorylation of several Kv1 channels. Consequently, we investi-
gated if these proteins were expressed by human T cells and affect the
redistribution of Kv1.3 to the IS.
We could detect both PSD-95 and SAP97 in Jurkat cells (mRNA and protein).
Furthermore, both proteins co-immunoprecipitated with the Kv1.3 channel,
which implies a direct interaction between these proteins. We established Ju-
rkat cell lines that over-express mGFP tagged wild-type or a C-terminal trun-
cated Kv1.3 channel, which lack the canonical binding domain of PSD-95.
Also, we knocked down the PSD-95 gene in the mGFP-tagged WT Kv1.3 ex-
pressing cells.
We found that the redistribution of Kv1.3 channels exhibits different kinetics in
the wild-type and in the truncated ion channel expressing or PSD-95 knock-
down cells: wild-type channels accumulated in the contact region between T
and B cells even at the first minute, while the C-truncated channels diffused
slower to the IS, just like the wild-type channels of the PSD-95 knockdown
cells. Moreover, the accumulation of truncated Kv1.3 channels and WT chan-
nels expressed by PSD-95 knockdown cells was less pronounced as compared
to the wild-type. These results demonstrate that PSD-95 could control the redis-
tribution of Kv1.3 into the IS.
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Microglia, the major inflammatory cells of the brain, play a pivotal role in the
initiation and progression of Alzheimer’s Disease (AD) by either clearing am-
yloid-b deposits through phagocytic activity or by releasing cytotoxic sub-
stances and pro-inflammatory cytokines in response to activation by
amyloid-b aggregates, including amyloid-b oligomers (AbO). We here propose
microglial Kv1.3 channels as a novel pharmacological target for curbing the
harmful effects of Ab-induced microglia activation. Kv1.3 expression in-
creased in cultured microglia in response to stimulation with AbO as deter-
mined by electrophysiology, RT-PCR, Western Blotting and
immunohistochemistry. Similarly, microglia isolated from the brains of adult
5xFAD mice, a mouse model expressing high levels of Ab due to trangenes
with AD familial mutations, expressed higher levels of Kv1.3 than microglia
isolated from the brains of age-matched control mice. We further observed
strong Kv1.3 immunoreactivities in microglia associated with amyloid plaques
in brains of 5xFAD mice. Proof for the functional importance of Kv1.3 in mi-
croglia comes from our observations that the Kv1.3 blocker PAP-1 inhibits
AbO-stimulated nitric oxide production as well as microglia-mediated neuro-
toxicity in dissociated cultures and organotypic brain slices. A 6-week course
of daily PAP-1 injections also reduced the degree of microglia activation in
5xFADmice. In contrast, Kv1.3 blockade with PAP-1 does not affect phagocy-
tosis of Ab aggregates by microglia. These observations raise the exciting pos-
sibility that Kv1.3 blockers might preferentially inhibit microglia mediated
neuronal killing without affecting beneficial functions such as scavenging of
debris.
Supported by NIH (RO1GM076063, RO1AG010129 and R21AG038910) and
Alzheimer’s Association (NIRG-10-174150).
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Modeling Block of the Kv1.5 Channel by Cationophilic and Cationic
Ligands: Implications for General Mechanisms of the Inner Pore Block
in P-Loop Channels
Denis B. Tikhonov1, Boris S. Zhorov1,2.
1Sechenov Institute, RAS, St. Petersburg, Russian Federation,
2McMaster University, Hamilton, ON, Canada.Many small molecules of intriguingly different chemical structures bind in
the inner pore of potassium channels. Previous mutational, electrophysiolog-
ical, and ligand-binding experiments revealed common and diverse charac-
teristics of action of different ligands including ligand-channel
stoichiometries, voltage- and use-dependencies, and patterns of ligand-
sensing residues. However, generally accepted structural interpretations for
most of the available data are lacking. Here we used energy calculations
with experimentally based constraints to dock flecainide, ICAGEN-4, benzo-
caine, vernakalant, and AVE0118 into the inner pore of the Kv1.5 channel.
We arrived at ligand-binding models that for the first time explain: (i) the
different Hill coefficients, (ii) opposite voltage dependencies of cationic
and electroneutral cationophilic ligands, and (iii) effects of mutations of res-
idues, which do not face the pore, on the ligand action. Two concepts were
crucial for the modeling. First, the inner-pore block of a potassium channel
requires a cationic ‘‘blocking particle’’. A ligand that lacks a positively
charged group, blocks the channels not per se, but in a complex with a per-
meant cation. Second, flexible hydrophobic moieties of ligands have a ten-
dency to escape from the aqueous pore environment into subunit
interfaces. Previously these concepts have allowed to explain action of so
different ligands of potassium channels as correolide, propafenone, phenylal-
kylamines, and PAP-1-like immunosuppressants. The same concepts have
been successfully used to analyze structure-function relationships of phenyl-
alkylamines, benzothiazepines and dihydropyridines in calcium channels and
local anesthetics in sodium channels. Supported by RFBR to DBT and
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Development of Atomistic Models for Closed, Open and Open-Inactivated
States of hERG1 Channel using Rosetta Protein Modeling Suite and
Molecular Dynamics Simulations
Serdar Durdagi, Sumukh Deshpande, Henry Duff, Sergei Noskov.
University of Calgary, Calgary, AB, Canada.
The human ether-a-go-go related gene 1 (hERG1) K ion channel is a key el-
ement for the rapid component of the delayed rectified potassium current in
cardiac myocytes. It is essential for the normal repolarization phase of the
cardiac action potential. Loss of function mutations in hERG1 cause increased
duration of ventricular repolarization which leads to prolongation of the time
interval between Q and T waves of the body surface electrocardiogram (long
QT syndrome-LQTS). hERG1 Kþ channel is a homotetramer composed of
four identical homologous subunits each containing six transmembrane
(TM) helices S1-S6. Single hERG channels are either closed, open or inacti-
vated conformations depending on TM voltage. Although creation and valida-
tion of reliable 3D atomistic models of the hERG channel has been a key
target in molecular cardiology for last decade, there are no reported S1-S6
TM homology models of the channel in different states yet in literature. In
this study, we derived open, closed and open-inactivated states of hERG1 us-
ing ROSETTA protein modeling suite and side-chain placements are opti-
mized by molecular dynamics simulations. Although backbone templates
are modeled on available crystal structures of Kv1.2 and KcsA channels,
the missing parts are modeled de novo. Final models are evaluated for con-
sistency to the reported structural elements discovered mainly on the basis
of mutagenesis and electrophysiology. Closed state models are further vali-
dated by protein-protein docking using selective peptide toxin and available
experimental data on toxin foot-printing. Derived models of hERG1 in differ-
ent states offer an indispensable template for rational drug design as well as
better understanding of molecular mechanisms of hERG channel upon bind-
ing of openers or blockers.3446-Pos Board B307
Molecular Determinants of Pentamidine-Induced hERG Trafficking
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Isabelle Deschenes, Eckhard Ficker.
Case Western Reserve University, Cleveland, OH, USA.
Pentamidine is an anti-protozoical compound that clinically causes acquired
long QT syndrome which is associated with prolonged QT intervals, tachycar-
dias and sudden cardiac arrest. Pentamidine delays terminal repolarization in
human heart by blocking cardiac inward rectifier currents acutely. At the
same time, pentamidine reduces surface expression of the cardiac potassium
channel IKr/hERG. This is unusual in that acLQTS is caused most often by
direct block of the cardiac potassium current IKr/hERG. The present study
was designed to provide a more complete picture of how hERG surface ex-
pression is disrupted by pentamidine at the cellular and molecular level.
